CanCURE
The Canadian HIV Cure Enterprise (CanCURE) is a research collaboratory focused on studying HIV persistence during antiretroviral therapy and developing strategies towards a sustainable HIV remission. Our innovative scientific program is supported by the Canadian Institutes of Health Research (CIHR).
© IAS/photo: Steve Forrest
CanCURE Photo Gallery
Available Positions
Postdoctoral Fellow
Human Immunodeficiency Virus (HIV)-host interactions governing HIV persistence in different models of humanized mice. Dr. Eric Cohen, Montreal Clinical Research Institute (IRCM, Montreal)
PhD trainee/Postdoc
Immunity during HIV infection, Dr. Cecilia Costiniuk and Mohammad-Ali Jenabian, IR-MUHC, Montreal (2 positions available)
Postdoctoral Fellow
Immunity during HIV infection Dr. Cecilia Costiniuk, MUHC, McGill, Montreal
Publications
Abdel-Mohsen et al. Recommendations for measuring HIV reservoir size in cure-directed clinical trials. Nature Med. September 2020
Gantner et al. Single-cell TCR sequencing reveals phenotypically diverse clonally expanded cells harboring inducible HIV proviruses during ART. Nature Communications. August 2020
Zhang et al. Improving HIV Outgrowth by Optimizing Cell-Culture Conditions and Supplementing With all-trans Retinoic Acid. Frontiers in Microbiology. May 2020
Rabezanahary et al. Despite early antiretroviral therapy effector memory and follicular helper CD4 T cells are major reservoirs in visceral lymphoid tissues of SIV-infected macaques. Mucosal Immunol. Nov 2019